{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:28:38Z","timestamp":1784543318532,"version":"3.55.0"},"reference-count":40,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.3201\/eid2103.140634","type":"journal-article","created":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T15:43:17Z","timestamp":1422459797000},"page":"417-425","source":"Crossref","is-referenced-by-count":55,"title":["Risk Factors for Death from Invasive Pneumococcal Disease, Europe, 2010"],"prefix":"10.3201","volume":"21","author":[{"given":"Adoraci\u00f3n","family":"Navarro-Torn\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana Gomes","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frantiska","family":"Hruba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Luigi","family":"Lopalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Pastore-Celentano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J. Amato","family":"Gauci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Invasive Pneumococcal Disease Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2103.140634-201504160934-R1","first-page":"217","article-title":"Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance and impact of vaccines.","volume":"16","author":"Lynch","year":"2010","journal-title":"Curr Opin Pulm Med"},{"key":"key-10.3201\/eid2103.140634-201504160934-R2","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/clinids\/22.6.973","article-title":"Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex and geography in 7000 episodes of invasive disease.","volume":"22","author":"Scott","year":"1996","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2103.140634-201504160934-R3","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/cid\/cit721","article-title":"Seasonal drivers of pneumococcal disease incidence: impact of bacterial carriage and viral activity.","volume":"58","author":"Weinberger","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2103.140634-201504160934-R4","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/INF.0b013e31824f25b0","article-title":"Viral co-infection in children less than five years old with invasive pneumococcal disease.","volume":"31","author":"Launes","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid2103.140634-201504160934-R5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1086\/655828","article-title":"Risk of death from pneumococcal pneumonia is a stable serotype-associated property: a meta-analysis.","volume":"51","author":"Weinberger","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2103.140634-201504160934-R6","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1086\/374624","article-title":"Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential.","volume":"187","author":"Brueggemann","year":"2003","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2103.140634-201504160934-R7","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1183\/09031936.00041210","article-title":"The paradox in pneumococcal serotypes: highly invasive does not mean highly lethal.","volume":"36","author":"Pletz","year":"2010","journal-title":"Eur Respir J"},{"key":"key-10.3201\/eid2103.140634-201504160934-R8","doi-asserted-by":"publisher","first-page":"e1000348","DOI":"10.1371\/journal.pmed.1000348","article-title":"Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project.","volume":"7","author":"Johnson","year":"2010","journal-title":"PLoS Med"},{"key":"key-10.3201\/eid2103.140634-201504160934-R9","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1086\/600045","article-title":"Invasive pneumococcal disease among adults: association among serotypes, disease characteristics, and outcome.","volume":"49","author":"Jansen","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2103.140634-201504160934-R10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1473-3099(05)01280-6","article-title":"Epidemiological differences among pneumococcal serotypes.","volume":"5","author":"Hausdorff","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2103.140634-201504160934-R11","doi-asserted-by":"publisher","first-page":"9127","DOI":"10.1016\/j.vaccine.2011.09.112","article-title":"Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine.","volume":"29","author":"Miller","year":"2011","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2103.140634-201504160934-R12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/S0140-6736(12)61854-6","article-title":"Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomized trial.","volume":"381","author":"Palmu","year":"2013","journal-title":"Lancet"},{"key":"key-10.3201\/eid2103.140634-201504160934-R13","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination.","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet"},{"key":"key-10.3201\/eid2103.140634-201504160934-R14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/1471-2334-12-207","article-title":"Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.","volume":"12","author":"Weil-Olivier","year":"2012","journal-title":"BMC Infect Dis"},{"key":"key-10.3201\/eid2103.140634-201504160934-R15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1469-0691.2009.02724.x","article-title":"The antimicrobial resistance profile of Streptococcus pneumoniae.","volume":"15","author":"Reinert","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid2103.140634-201504160934-R16","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/01.inf.0000239266.20642.26","article-title":"Will reduction of antibiotic use reduce antibiotic resistance? The pneumococcus paradigm.","volume":"25","author":"Dagan","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid2103.140634-201504160934-R17","unstructured":"European Antimicrobial Resistance Surveillance Network (EARS-Net). Antimicrobial resistance interactive database (EARS-Net) [cited 2014 Mar 2]. http:\/\/www.ecdc.europa.eu\/en\/healthtopics\/antimicrobial_resistance\/database\/Pages\/database.aspx"},{"key":"key-10.3201\/eid2103.140634-201504160934-R18","unstructured":"European Centre for Disease Prevention and Control. Surveillance of invasive pneumococcal disease in Europe, 2010 [cited 2014 Mar 3]. http:\/\/www.ecdc.europa.eu\/en\/publications\/publications\/invasive-pneumoccocal-disease-surveillance-2010.pdf"},{"key":"key-10.3201\/eid2103.140634-201504160934-R19","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1183\/09031936.00176309","article-title":"Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia.","volume":"36","author":"Luj\u00e1n","year":"2010","journal-title":"Eur Respir J"},{"key":"key-10.3201\/eid2103.140634-201504160934-R20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2334-4-21","article-title":"Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited.","volume":"4","author":"Martens","year":"2004","journal-title":"BMC Infect Dis"},{"key":"key-10.3201\/eid2103.140634-201504160934-R21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1086\/377534","article-title":"An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome.","volume":"37","author":"Yu","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2103.140634-201504160934-R22","doi-asserted-by":"publisher","first-page":"e88406","DOI":"10.1371\/journal.pone.0088406","article-title":"Initial effects of the national PCV7 childhood immunization program on adult invasive pneumococcal disease.","volume":"9","author":"Regev-Yochay","year":"2014","journal-title":"PLoS ONE"},{"key":"key-10.3201\/eid2103.140634-201504160934-R23","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1128\/CVI.00110-08","article-title":"Effects of ageing and gender on naturally acquired antibodies to pneumococcal capsular polysaccharides and virulence-associated proteins.","volume":"15","author":"Simell","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"key-10.3201\/eid2103.140634-201504160934-R24","unstructured":"European Centre for Disease Prevention and Control. Vaccine schedule. Recommended immunisations for pneumococcal disease [cited 2014 Apr 7]. http:\/\/vaccine-schedule.ecdc.europa.eu\/Pages\/Scheduler.aspx"},{"key":"key-10.3201\/eid2103.140634-201504160934-R25","doi-asserted-by":"publisher","first-page":"e1000081","DOI":"10.1371\/journal.pmed.1000081","article-title":"Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study.","volume":"6","author":"Harboe","year":"2009","journal-title":"PLoS Med"},{"key":"key-10.3201\/eid2103.140634-201504160934-R26","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1378\/chest.130.3.800","article-title":"Hospitalized community-acquired pneumonia due to Streptococcus pneumoniae. Has resistance to antibiotics decreased?","volume":"130","author":"Vall\u00e8s","year":"2006","journal-title":"Chest"},{"key":"key-10.3201\/eid2103.140634-201504160934-R27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/aje\/kwq126","article-title":"Long-term mortality in patients diagnosed with pneumococcal meningitis: a Danish nationwide cohort.","volume":"172","author":"Roed","year":"2010","journal-title":"Am J Epidemiol"},{"key":"key-10.3201\/eid2103.140634-201504160934-R28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/INF.0b013e318187e215","article-title":"Association of serotype of Streptococcus pneumoniae with risk of severe and fatal outcome.","volume":"28","author":"R\u00fcckinger","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid2103.140634-201504160934-R29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3201\/eid1901.120741","article-title":"Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales.","volume":"19","author":"Ladhani","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2103.140634-201504160934-R30","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1128\/JCM.01917-12","article-title":"Changes in molecular epidemiology of Streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales.","volume":"51","author":"Pichon","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2103.140634-201504160934-R31","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1128\/IAI.00724-13","article-title":"Surface charge of Streptococcus pneumoniae predicts serotype distribution.","volume":"81","author":"Li","year":"2013","journal-title":"Infect Immun"},{"key":"key-10.3201\/eid2103.140634-201504160934-R32","doi-asserted-by":"publisher","first-page":"e39150","DOI":"10.1371\/journal.pone.0039150","article-title":"Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes.","volume":"7","author":"van Hoek","year":"2012","journal-title":"PLoS ONE"},{"key":"key-10.3201\/eid2103.140634-201504160934-R33","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12325-013-0007-6","article-title":"The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review.","volume":"30","author":"Myint","year":"2013","journal-title":"Adv Ther"},{"key":"key-10.3201\/eid2103.140634-201504160934-R34","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1086\/499242","article-title":"Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen.","volume":"42","author":"Sj\u00f6str\u00f6m","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2103.140634-201504160934-R35","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1128\/AAC.01594-09","article-title":"Susceptibility of recently collected Spanish pneumococci nonsusceptible to oral penicillin from serotypes not included in the 7-valent conjugate vaccine.","volume":"54","author":"Fenoll","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.3201\/eid2103.140634-201504160934-R36","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2334-11-323","article-title":"Clinical outcome of pneumococcal meningitis during the emergence of penicillin-resistant Streptococcus pneumoniae: an observational study.","volume":"11","author":"Gouveia","year":"2011","journal-title":"BMC Infect Dis"},{"key":"key-10.3201\/eid2103.140634-201504160934-R37","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1017\/S0950268811001816","article-title":"Risk factors for 30-day mortality in adult patients with pneumococcal bacteraemia, and the impact of antimicrobial resistance on clinical outcomes.","volume":"140","author":"Song","year":"2012","journal-title":"Epidemiol Infect"},{"key":"key-10.3201\/eid2103.140634-201504160934-R38","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2165\/11585310-000000000-00000","article-title":"Bacteremic pneumococcal pneumonia: current therapeutic options.","volume":"71","author":"Feldman","year":"2011","journal-title":"Drugs"},{"key":"key-10.3201\/eid2103.140634-201504160934-R39","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s40266-013-0060-5","article-title":"Preventing pneumococcal disease in the elderly. Recent advances in vaccines and implications for clinical practice.","volume":"30","author":"Vila-Corcoles","year":"2013","journal-title":"Drugs Aging"},{"key":"key-10.3201\/eid2103.140634-201504160934-R40","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1007\/s00018-012-1234-8","article-title":"Serotype-independent pneumococcal vaccines.","volume":"70","author":"Miyaji","year":"2013","journal-title":"Cell Mol Life Sci"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/21\/3\/14-0634_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T23:20:10Z","timestamp":1732922410000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/21\/3\/14-0634_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2103.140634","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3]]}}}